Article

Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): A randomized, double-blind, placebo-controlled trial

2017-09-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7818ede3-8b0a-5946-a435-884f98773f94
DOI: 10.1016/j.atherosclerosissup.2017.08.003

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): A randomized, double-blind, placebo-controlled trialDOI 10.1016/j.atherosclerosissup.2017.08.003Read

Severe hypertriglyceridemia: Existing and emerging therapiesSemantic proximity Read

ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIASemantic proximity Read

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.Semantic proximity Read

Updates in Small Interfering RNA for the Treatment of DyslipidemiasSemantic proximity Read

Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial.Semantic proximity Read

Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteriaSemantic proximity Read

Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemiaSemantic proximity Read

Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized TrialSemantic proximity Read

Novel Therapeutics for Familial Chylomicronemia SyndromeSemantic proximity Read

RNA Silencing in the Management of DyslipidemiasSemantic proximity Read

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.Semantic proximity Read

Total Synthesis and Bioactivity Investigation of a Chiral DiacylglycerolSemantic proximity Read